Consistent with the hypothesis that BDNF functions to modulate synaptic strength through the CAMKII calcium signalling pathway, the CAMKII inhibitor KN-93 blocks the effect of BDNF on glioma glutamatergic current amplitude, whereas the inactive analogue KN-92 does not (Fig. 2d,e). This evidence concerns the gene BDNF and glioma.